Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,416.00
Bid: 12,408.00
Ask: 12,410.00
Change: -12.00 (-0.10%)
Spread: 2.00 (0.016%)
Open: 12,474.00
High: 12,480.00
Low: 12,350.00
Prev. Close: 12,428.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Earnings come in mixed as investors watch US data, Fed

Thu, 31st Jul 2014 12:04

- Shell, BG Group and Intu lead the risers- Weir, Schroders and Lloyds fall- Afren drops after suspending directors- US data and Fed keep investors cautioustechMARK 2,763.54 -0.57%FTSE 100 6,763.04 -0.15%FTSE 250 15,495.73 -0.86%London stocks were trading in the red for a second straight day on Thursday as investors gave a mixed reaction to a wave of blue-chip corporate earnings and showed their nerves amid policy tightening speculation in the States. Results from Shell, BG Group, Intu Properties impressed the market in morning trade, offset by falls from Weir, Schroders and Lloyds. Meanwhile, the share price of oil explorer Afren plummeted after the company suspended two directors.The FTSE 100 was down 0.15% at 6,763 around midday.The Federal Reserve decided on Wednesday night to taper stimulus by $10bn a month for the sixth straight time, putting the central bank on course to end its quantitative easing programme in October.However, with the end of monetary stimulus now fast approaching, Wednesday's better-than-expected US growth figures - economy expanded by 4% in second quarter - traders are now concerned that policymakers could be tempted to raise interest rates sooner than expected.Jasper Lawler, a market analyst at CMC Markets, said that Fed Chair Janet Yellen had aimed to be "dovish while demonstrating a gradual hawkish shift" in the Fed's statement on Wednesday. However, with growth above expectations and inflation running at the target 2% amid a strengthening labour market, he said the "markets didn't really buy the Fed's attempt at dovishness"."After growth and inflation, Friday's non-farm payrolls will be the third point in the rate hike 'triangle', another 200k+ report and unemployment below 6% means the Fed really have no excuses not to tighten," he said.The consensus forecast for the all-important 'official' US employment report is for a 231,000 gain in non-farm payrolls in July, down from an impressive 288,000 in June. The unemployment rate is expected to remain unchanged after falling to 6.1%, its lowest since September 2008.As for Thursday's session, the focus will be on weekly US initial jobless claims, which are predicted to have risen to 300,000 from a post-recession low of 284,000 the previous week.Earnings come in mixedOil major Royal Dutch Shell impressed with shares rising strongly after saying earnings more than doubled in the second quarter to $5.1bn, even when including a $1bn net charge due to impairments. Natural gas group BG Group was also higher as it lifted its interim by a tenth after a strong second quarter led to a 9% increase in earnings per share in the first half.Intu Properties was in favour after the real estate firm said higher rental income helped to lift underlying earnings as the letting market showed "encouraging signs of improvement".Heading the other way banking group Lloyds which underwhelmed after saying that underlying profits improved by 32% to £3.82bn in the first half of the year, ahead of the £3.6bn consensus forecast. This was achieved despite a 2.2% fall in total underlying income to £9.25bn.Engineer Weir was in the red after reporting that profits slid 6% in the first half, reflecting adverse foreign exchange currency exchange rate movements and challenging conditions in the mining industry. Even though it unexpectedly hiked its half-year dividend 50% to 24p, shares in asset manager Schroders slipped after it sounded a note of caution about the retail investor market. Meanwhile, telecoms group BT and drinks giant Diageo both rose after their results, while engine maker Rolls-Royce and drugs group AstraZeneca underwhelmed.On the FTSE 250, Afren shares plummeted after the company said that it has suspended its chief executive officer and chief operating officer as an investigation found "the receipt of unauthorised payments potentially for the benefit of the CEO and COO".FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,583.50p +3.80%Royal Dutch Shell 'A' (RDSA) 2,454.00p +3.00%Intu Properties (INTU) 328.60p +2.59%BG Group (BG.) 1,203.00p +1.91%BT Group (BT.A) 390.80p +0.75%GlaxoSmithKline (GSK) 1,435.00p +0.70%BP (BP.) 484.95p +0.66%Diageo (DGE) 1,799.00p +0.56%Antofagasta (ANTO) 820.50p +0.55%easyJet (EZJ) 1,297.00p +0.54%FTSE 100 - FallersWeir Group (WEIR) 2,556.00p -4.20%Schroders (SDR) 2,417.00p -3.28%St James's Place (STJ) 732.00p -3.05%Lloyds Banking Group (LLOY) 74.40p -2.63%Barratt Developments (BDEV) 348.40p -2.60%GKN (GKN) 342.90p -2.39%3i Group (III) 377.70p -2.38%Aggreko (AGK) 1,729.00p -2.26%Sports Direct International (SPD) 670.00p -2.12%Petrofac Ltd. (PFC) 1,089.00p -2.07%FTSE 250 - RisersLaird (LRD) 285.80p +6.76%Hochschild Mining (HOC) 163.40p +2.90%Bodycote (BOY) 710.50p +2.53%Domino's Pizza Group (DOM) 547.00p +1.86%Countrywide (CWD) 524.50p +1.84%Barr (A.G.) (BAG) 661.00p +1.69%Workspace Group (WKP) 607.50p +1.59%Inchcape (INCH) 647.50p +1.57%Thomas Cook Group (TCG) 123.20p +1.07%Rightmove (RMV) 2,258.00p +1.07%FTSE 250 - FallersAfren (AFR) 111.50p -25.07%IP Group (IPO) 181.30p -4.58%Man Group (EMG) 120.50p -4.44%Pace (PIC) 322.60p -4.39%Supergroup (SGP) 1,019.00p -4.23%Bank of Georgia Holdings (BGEO) 2,417.00p -3.09%Homeserve (HSV) 295.30p -2.93%JD Sports Fashion (JD.) 380.10p -2.91%Jupiter Fund Management (JUP) 382.70p -2.87%Ocado Group (OCDO) 333.40p -2.71%BC
More News
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.